Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

A longitudinal study assessing differences in causes of death among housed and homeless people diagnosed with HIV in San Francisco

Authors: Nancy A. Hessol, Monica Eng, Annie Vu, Sharon Pipkin, Ling C. Hsu, Susan Scheer

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

San Francisco has implemented several programs addressing the needs of two large vulnerable populations: people living with HIV and those who are homeless. Assessment of these programs on health outcomes is paramount for reducing preventable deaths.

Methods

Individuals diagnosed with HIV/AIDS and reported to the San Francisco Department of Public Health HIV surveillance registry, ages 13 years or older, who resided in San Francisco at the time of diagnosis, and who died between January 1, 2002, and December 31, 2016 were included in this longitudinal study. The primary independent variable was housing status, dichotomized as ever homeless since diagnosed with HIV, and the dependent variables were disease-specific causes of death, as noted on the death certificate. The Cochran-Armitage test measured changes in the mortality rates over time and unadjusted and adjusted Poisson regression models measured prevalence ratios (PR) and 95% confidence intervals (CI) for causes of death.

Results

A total of 4158 deceased individuals were included in the analyses: the majority were male (87%), ages 40–59 years old at the time of death (64%), non-Hispanic White (60%), men who have sex with men (54%), had an AIDS diagnosis prior to death (87%), and San Francisco residents at the time of death (63%). Compared to those who were housed, those who were homeless were more likely to be younger at time of death, African American, have a history of injecting drugs, female or transgender, and were living below the poverty level (all p values < 0.0001). Among decedents who were SF residents at the time of death, there were declines in the proportion of deaths due to AIDS-defining conditions (p < 0.05) and increases in accidents, cardiomyopathy, heart disease, ischemic disease, non-AIDS cancers, and drug overdoses (p < 0.05). After adjustment, deaths due to mental disorders (aPR = 1.63, 95% CI 1.24, 2.14) were more likely and deaths due to non-AIDS cancers (aPR = 0.63, 95% CI 0.44, 0.89) were less likely among those experiencing homelessness.

Conclusions

Additional efforts are needed to improve mental health services to homeless people with HIV and prevent mental-health related mortality.
Literature
3.
go back to reference Hibbs JR, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331(5):304–9.CrossRef Hibbs JR, Benner L, Klugman L, et al. Mortality in a cohort of homeless adults in Philadelphia. N Engl J Med. 1994;331(5):304–9.CrossRef
4.
go back to reference Barrow SM, Herman DB, Cordova P, Struening EL. Mortality among homeless shelter residents in New York City. Am J Public Health. 1999;89(4):529–34.CrossRef Barrow SM, Herman DB, Cordova P, Struening EL. Mortality among homeless shelter residents in New York City. Am J Public Health. 1999;89(4):529–34.CrossRef
5.
go back to reference Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189–95.CrossRef Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189–95.CrossRef
6.
go back to reference Khanijow K, Hirozawa A, Ancock B, Hsu LC, Bamberger J, Schwarcz SK. Difference in survival between housed and homeless individuals with HIV, San Francisco, 2002-2011. J Health Care Poor Underserved. 2015;26(3):1005–18.CrossRef Khanijow K, Hirozawa A, Ancock B, Hsu LC, Bamberger J, Schwarcz SK. Difference in survival between housed and homeless individuals with HIV, San Francisco, 2002-2011. J Health Care Poor Underserved. 2015;26(3):1005–18.CrossRef
7.
go back to reference Schwarcz SK, Hsu LC, Vittinghoff E, Vu A, Bamberger JD, Katz MH. Impact of housing on the survival of persons with AIDS. BMC Public Health. 2009;9:220.CrossRef Schwarcz SK, Hsu LC, Vittinghoff E, Vu A, Bamberger JD, Katz MH. Impact of housing on the survival of persons with AIDS. BMC Public Health. 2009;9:220.CrossRef
8.
go back to reference Clemenzi-Allen A, Geng E, Christopoulos K, et al. Degree of Housing Instability Shows Independent “Dose-Response” With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2018;5(3):ofy035.CrossRef Clemenzi-Allen A, Geng E, Christopoulos K, et al. Degree of Housing Instability Shows Independent “Dose-Response” With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2018;5(3):ofy035.CrossRef
13.
go back to reference Zetola NM, Klausner JD, Haller B, Nassos P, Katz MH. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA. 2007;297(10):1061–2.CrossRef Zetola NM, Klausner JD, Haller B, Nassos P, Katz MH. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA. 2007;297(10):1061–2.CrossRef
14.
go back to reference Schwarcz S, Hsu LC, Scheer S. Disparities and trends in viral suppression during a transition to a “test and treat” approach to the HIV epidemic, San Francisco, 2008-2012. J Acquir Immune Defic Syndr. 2015;70(5):529–37.CrossRef Schwarcz S, Hsu LC, Scheer S. Disparities and trends in viral suppression during a transition to a “test and treat” approach to the HIV epidemic, San Francisco, 2008-2012. J Acquir Immune Defic Syndr. 2015;70(5):529–37.CrossRef
16.
go back to reference Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Hyattsville: National Center for Health Statistics; 1999. Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Hyattsville: National Center for Health Statistics; 1999.
17.
go back to reference Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection-United States, 2014. MMWR Recomm Rep. 2014;63(RR-03):1–10. Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection-United States, 2014. MMWR Recomm Rep. 2014;63(RR-03):1–10.
18.
go back to reference U.S. Census Bureau, 2006-2010 American community survey: selected economic characteristics. Washington, D.C.: U.S. Department of Commerce. U.S. Census Bureau, 2006-2010 American community survey: selected economic characteristics. Washington, D.C.: U.S. Department of Commerce.
19.
go back to reference SAS Institute Inc, editor. ed SAS/STAT User’s Guide, Version 9.4: Cary, SAS Institute Inc; 2014. SAS Institute Inc, editor. ed SAS/STAT User’s Guide, Version 9.4: Cary, SAS Institute Inc; 2014.
20.
go back to reference Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRef Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.CrossRef
21.
go back to reference Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306.CrossRef Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306.CrossRef
22.
go back to reference Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRef Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRef
23.
go back to reference Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2004;16(2):199–211.CrossRef Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2004;16(2):199–211.CrossRef
24.
go back to reference Herbeck DM, Fitek DJ, Svikis DS, Montoya ID, Marcus SC, West JC. Treatment compliance in patients with comorbid psychiatric and substance use disorders. Am J Addict. 2005;14(3):195–207.CrossRef Herbeck DM, Fitek DJ, Svikis DS, Montoya ID, Marcus SC, West JC. Treatment compliance in patients with comorbid psychiatric and substance use disorders. Am J Addict. 2005;14(3):195–207.CrossRef
25.
go back to reference Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–9.CrossRef Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–9.CrossRef
26.
go back to reference Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103.CrossRef Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103.CrossRef
27.
go back to reference Yehia BR, Stephens-Shield AJ, Momplaisir F, et al. Health outcomes of HIV-infected people with mental illness. AIDS Behav. 2015;19(8):1491–500.CrossRef Yehia BR, Stephens-Shield AJ, Momplaisir F, et al. Health outcomes of HIV-infected people with mental illness. AIDS Behav. 2015;19(8):1491–500.CrossRef
28.
go back to reference Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(6 Suppl):85–100.CrossRef Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(6 Suppl):85–100.CrossRef
29.
go back to reference Hall G, Singh T, Lim SW. Supportive housing promotes AIDS-free survival for chronically homeless HIV positive persons with behavioral health conditions. AIDS Behav. 2019;23(3):776–83.CrossRef Hall G, Singh T, Lim SW. Supportive housing promotes AIDS-free survival for chronically homeless HIV positive persons with behavioral health conditions. AIDS Behav. 2019;23(3):776–83.CrossRef
30.
go back to reference Buchanan D, Kee R, Sadowski LS, Garcia D. The health impact of supportive housing for HIV-positive homeless patients: a randomized controlled trial. Am J Public Health. 2009;99(Suppl 3):S675–80.CrossRef Buchanan D, Kee R, Sadowski LS, Garcia D. The health impact of supportive housing for HIV-positive homeless patients: a randomized controlled trial. Am J Public Health. 2009;99(Suppl 3):S675–80.CrossRef
31.
go back to reference Milloy MJ, Marshall BD, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef Milloy MJ, Marshall BD, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef
32.
go back to reference Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844–45. Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844–45.
33.
go back to reference Folsom DP, Hawthorne W, Lindamer L, et al. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry. 2005;162(2):370–6.CrossRef Folsom DP, Hawthorne W, Lindamer L, et al. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry. 2005;162(2):370–6.CrossRef
34.
go back to reference Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148(10):728–36.CrossRef Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148(10):728–36.CrossRef
35.
go back to reference Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009;23(17):2337–45.CrossRef Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009;23(17):2337–45.CrossRef
36.
go back to reference Crum-Cianflone NF, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors’ reply. AIDS. 2009;23(13):1791–2.CrossRef Crum-Cianflone NF, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors’ reply. AIDS. 2009;23(13):1791–2.CrossRef
37.
go back to reference Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52(5):611–22.CrossRef Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52(5):611–22.CrossRef
38.
go back to reference Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.CrossRef Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.CrossRef
39.
go back to reference Lima VD, Hogg RS, Harrigan PR, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21(6):685–92.CrossRef Lima VD, Hogg RS, Harrigan PR, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21(6):685–92.CrossRef
40.
go back to reference Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161(2):277–84.CrossRef Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161(2):277–84.CrossRef
41.
go back to reference Trepka MJ, Sheehan DM, Fennie KP, Niyonsenga T, Lieb S, Maddox LM. Completeness of HIV reporting on death certificates for Floridians reported with HIV infection, 2000-2011. AIDS Care. 2016;28(1):98–103.CrossRef Trepka MJ, Sheehan DM, Fennie KP, Niyonsenga T, Lieb S, Maddox LM. Completeness of HIV reporting on death certificates for Floridians reported with HIV infection, 2000-2011. AIDS Care. 2016;28(1):98–103.CrossRef
42.
go back to reference McGivern L, Shulman L, Carney JK, Shapiro S, Bundock E. Death certification errors and the effect on mortality statistics. Public Health Rep. 2017;132(6):669–75.CrossRef McGivern L, Shulman L, Carney JK, Shapiro S, Bundock E. Death certification errors and the effect on mortality statistics. Public Health Rep. 2017;132(6):669–75.CrossRef
Metadata
Title
A longitudinal study assessing differences in causes of death among housed and homeless people diagnosed with HIV in San Francisco
Authors
Nancy A. Hessol
Monica Eng
Annie Vu
Sharon Pipkin
Ling C. Hsu
Susan Scheer
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7817-7

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue